- Industry Solutions
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
- Right block
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Rising drug prices and their associated impacts have led many states to propose and pass legislation to increase visibility into drug pricing. More than 20 states have these laws on their books, and now pharmaceutical manufacturers must figure out how to effectively manage and comply with these complex and diverse requirements.
Join Model N and our special guest Rachel Jao, Head of Commercial Strategy from Global Pricing Innovations (GPI) for a of 30-minute webinar, where we’ll talk about the ins and outs of navigating the ever-changing environment of state drug price transparency mandates. We’ll discuss trends, best practices, and innovative approaches for ensuring compliance.
Since each state has its own requirements for what, when, and how to report, getting a handle on these mandates can be tedious and challenging. In the first Transparency Talk, we’ll provide an overview of the current regulatory environment and discuss the associated operational and compliance-related challenges. We’ll also give you a brief look at Model N Price Transparency Management – our innovative, purpose-built solution that streamlines reporting and mitigates risk of non-compliance.
As part of their drug price transparency mandates, many states require that pharmaceutical manufacturers submit 30-day wholesale acquisition cost (WAC) information. But calculating and maintaining 30-day or annual WAC data is manually intensive. In our second Transparency Talk, we’ll highlight how you can automate these 30-day calculations to streamline the process of providing cost of treatment data to requesting states.
Register today to discover trends, best practices, and innovative approaches for ensuring compliance with state price transparency regulations.
Please look for an email confirmation shortly with webinar details to add to your calendar.
Thank you for your interest in Model N. Please submit the form and our sales team will contact you within 24 hours.
We look forward to responding within one business day.